HomeInsightsStock Comparison

Glenmark Pharmaceuticals Ltd vs Innova Captab Ltd Stock Comparison

Glenmark Pharmaceuticals Ltd vs Innova Captab Ltd Stock Comparison

Last Updated on: Jun 10, 2025

Key Highlights

  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 1628 as of 10 Jun 11:08.
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 27.2 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 5814 crore on March 2020 to ₹ 27019 crore on March 2024 . This represents a CAGR of 35.97% over 5 yearsThe Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 2564 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 3267 crore as compare to the Dec '24 revenue of ₹ 3418 crore. This represent the decline of -4.41% The revenue of Innova Captab Ltd for the Mar '25 is ₹ 318.12 crore as compare to the Dec '24 revenue of ₹ 320.79 crore. This represent the decline of -0.83%.
  • The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 199.89 crore as compare to the Dec '24 ebitda of ₹ 631.36 crore. This represent the decline of -68.34% The ebitda of Innova Captab Ltd for the Mar '25 is ₹ 51.07 crore as compare to the Dec '24 ebitda of ₹ 50.89 crore. This represent the growth of 0.35%.
  • The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 4.38 crore over 8 quarters. This represents a CAGR of -84.09% The net profit of Innova Captab Ltd changed from ₹ 17.59 crore to ₹ 29.57 crore over 8 quarters. This represents a CAGR of 29.66% .
  • The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 1.37 % on March 2024 . This represents a CAGR of -23.44% over 5 yearsThe Dividend Payout of Innova Captab Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
  • The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.

About Innova Captab Ltd

  • Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
  • Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
  • Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
  • Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark receives DCGI approval to launch oncology drug BRUKINSA in India

Glenmark Pharmaceuticals has announced the upcoming launch of zanubrutinib in India follow...

Read more

09 Jun 2025 11:04

News

Glenmark Pharma rises after zanubrutinib launch in India

Co-developed with global oncology leader BeOne Medicines, zanubrutinib will be marketed un...

Read more

09 Jun 2025 12:02

News

Board of Glenmark Pharmaceuticals recommends final dividend

Glenmark Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

24 May 2025 11:52

News

Glenmark Pharmaceuticals grants 1.19 lakh stock options under ESOS

The Board of Glenmark Pharmaceuticals at its meeting held on 22 May 2025 has granted 1,19,...

Read more

22 May 2025 16:03

News

Glenmark Pharmaceuticals announces board meeting date

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

13 May 2025 15:58

News

Ichnos Glenmark Innovation receives USFDA fast track designation for ISB 2001

IGI (Ichnos Glenmark Innovation), a global, fully integrated clinical-stage biotechnology ...

Read more

05 May 2025 19:16

Innova Captab Ltd News Hub

News

Innova Captab announces board meeting date

Innova Captab will hold a meeting of the Board of Directors of the Company on 19 May 2025....

Read more

13 May 2025 15:59

News

Innova Captab to table results

Innova Captab will hold a meeting of the Board of Directors of the Company on 5 February 2...

Read more

30 Jan 2025 11:36

News

Innova Captab starts commercial production in Jammu facility

The said facility comprises four dedicated manufacturing blocks, including general, cephal...

Read more

15 Jan 2025 12:23

News

Innova Captab commences commercial production at its facility in Jammu

Innova Captab has commenced commercial production at its state-of-the-art manufacturing fa...

Read more

14 Jan 2025 19:43

News

Innova Captab to announce Quarterly Result

Innova Captab will hold a meeting of the Board of Directors of the Company on 7 November 2...

Read more

30 Oct 2024 17:25

News

Innova Captab to hold AGM

Innova Captab announced that the 20th Annual General Meeting (AGM) of the company will be ...

Read more

26 Aug 2024 14:52

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Innova Captab Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Innova Captab Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Innova Captab Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Innova Captab Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 45,108 Cr while Market cap of Innova Captab Ltd is 5,077 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Innova Captab Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Innova Captab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Innova Captab Ltd?

As of June 10, 2025, the Glenmark Pharmaceuticals Ltd stock price is INR ₹1598.45. On the other hand, Innova Captab Ltd stock price is INR ₹887.35.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Innova Captab Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Innova Captab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions